Further to the reminder issued to contractors yesterday and corrected below, NICPLD have advised that enrolment for the final EL webinars is no longer open on the NICPLD website, however places are still available. Those who wish to attend are asked to email Helen Hirst (NICPLD Community Pharmacy Lead for EL) h.hirst@qub.ac.uk to enrol and use the relevant links provided below to join the webinar.
Please also see the corrected date and time information and note that the final webinars will be taking place today at 12.30pm and tomorrow at 7pm.
NICPLD recently informed registrants through their newsletter of a series of upcoming information webinars on the introduction of experiential learning (EL) for pharmacy undergraduate students commencing in Autumn 2023. The final information webinars will be taking place Wednesday 22 February and Thursday 23 February.
SUMMARY
Experiential learning will involve students from Queen’s University and the University of Ulster undertaking a total of 12 week long placements in community, general practice and hospital settings, spread across their MPharm programme, 3 of which will be spent in a community pharmacy.
The placements will commence in participating community pharmacies in November 2023.
During their placements, students will be required to complete five designated learning activities, which should be overseen by an accredited pharmacist who has completed the necessary training to act as an EL “Practice Supervisor”.
Pharmacists acting as a Practice Supervisor are required to have been registered for a minimum of one year.
Contractors and pharmacists who are interested in offering EL will be provided with an overview and will be able to ask questions and/or express their interest at the end of the webinars.
Funding of £592 per week will be paid to Contractors providing EL placements at their pharmacies, with training and accreditation expenses also being allocated in 2022/23 for those pharmacists wishing to become Practice Supervisors.
Note that the remaining information webinars will be taking place Wednesday 22 February at 12.30pm and Thursday 23 February at 7pm.
Please ensure that your pharmacist(s) are made of aware of the webinars if you are considering becoming an EL provider at any of the pharmacy locations in which they work.
Please feel free to contact a member of the CPNI team should you have any questions, or alternatively queries can also be directed to NICPLD.
Kind regards
SENT ON BEHALF OF Gerard Greene Chief Executive
Dear Colleague
NICPLD recently informed registrants through their newsletter of a series of upcoming information webinars on the introduction of experiential learning (EL) for pharmacy undergraduate students commencing in Autumn 2023. The final information webinars will be taking place tomorrow, Wednesday 22 February and those who wish to attend can do so by enrolling on the NICPLD website here.
SUMMARY
Experiential learning will involve students from Queen’s University and the University of Ulster undertaking a total of 12 week long placements in community, general practice and hospital settings, spread across their MPharm programme, 3 of which will be spent in a community pharmacy.
The placements will commence in participating community pharmacies in November 2023.
During their placements, students will be required to complete five designated learning activities, which should be overseen by an accredited pharmacist who has completed the necessary training to act as an EL “Practice Supervisor”.
Pharmacists acting as a Practice Supervisor are required to have been registered for a minimum of one year.
Contractors and pharmacists who are interested in offering EL will be provided with an overview and will be able to ask questions and/or express their interest at the end of the webinars.
Funding of £592 per week will be paid to Contractors providing EL placements at their pharmacies, with training and accreditation expenses also being allocated in 2022/23 for those pharmacists wishing to become Practice Supervisors.
Note that the remaining information webinars will be taking place tomorrow, Wednesday 22 February at 1.30pm and 7pm.
Please ensure that your pharmacist(s) are made of aware of the webinars if you are considering becoming an EL provider at any of the pharmacy locations in which they work.
Please feel free to contact a member of the CPNI team should you have any questions, or alternatively queries can also be directed to NICPLD.
Kind regards
SENT ON BEHALF OF Gerard Greene Chief Executive
Dear Colleague
The second update of concessionary prices were granted today for February 2023:
Drug
Pack Size
Concessionary Price
Amoxicillin 125mg/5ml oral suspension
100
£4.05
Amoxicillin 125mg/5ml oral suspension sugar free
100
£3.89
Amoxicillin 250mg/5ml oral suspension sugar free
100
£3.60
Amoxicillin 500mg capsules
15
£2.15
Amoxicillin 500mg capsules
21
£3.05
Bimatoprost 100micrograms/ml eye drops
3
£4.06
Brinzolamide 10mg/ml eye drops
5
£3.18
Carbocisteine 250mg/5ml oral solution
300
£8.20
Carbocisteine 375mg capsules
120
£10.49
Chloramphenicol 1% eye ointment
4
£4.30
Chlorpromazine 100mg tablets
28
£26.50
Chlorpromazine 25mg tablets
28
£26.50
Chlorpromazine 50mg tablets
28
£26.50
Cinacalcet 30mg tablets
28
£12.50
Citalopram 40mg/ml oral drops sugar free
15
£9.70
Clarithromycin 125mg/5ml oral suspension
70
£4.99
Clarithromycin 250mg tablets
14
£4.78
Clarithromycin 500mg tablets
14
£10.20
Co-careldopa 25mg/100mg tablets
100
£7.60
Co-codamol 30mg/500mg effervescent tablets
32
£3.77
Co-codamol 30mg/500mg effervescent tablets
100
£11.78
Colecalciferol 1,000unit capsules
30
£8.25
Co-trimoxazole 80mg/400mg tablets
28
£3.96
Cyclizine 50mg/1ml solution for injection ampoules
5
£10.70
Digoxin 250microgram tablets
28
£4.55
Digoxin 62.5microgram tablets
28
£4.83
Docusate 50mg/5ml oral solution sugar free
300
£19.89
Donepezil 10mg tablets
28
£1.26
Dosulepin 25mg capsules
28
£5.60
Duloxetine 30mg gastro-resistant capsules
28
£3.20
Finasteride 5mg tablets
28
£4.30
Flucloxacillin 250mg/5ml oral solution
100
£3.91
Frovatriptan 2.5mg tablets
6
£13.81
Hydroxocobalamin 1mg/1ml solution for injection ampoules
5
£12.27
Levetiracetam 100mg/ml oral solution sugar free
300
£11.98
Mebeverine 135mg tablets
100
£8.37
Methocarbamol 750mg tablets
100
£11.46
Mometasone 0.1% ointment
30
£4.37
Mycophenolate mofetil 500mg tablets
50
£8.68
Paracetamol 250mg/5ml oral suspension sugar free
200
£9.40
Pregabalin 300mg capsules
56
£3.50
Rabeprazole 10mg gastro-resistant tablets
28
£6.65
Ramipril 10mg tablets
28
£1.32
Rasagiline 1mg tablets
28
£4.30
Risedronate sodium 35mg tablets
4
£2.90
Telmisartan 80mg tablets
28
£3.59
Temazepam 10mg tablets
28
£21.74
Temazepam 20mg tablets
28
£23.61
Venlafaxine 75mg tablets
56
£12.50
Zolmitriptan 2.5mg tablets
12
£27.50
Zolmitriptan 2.5mg tablets
6
£13.75
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter.
Concessionary prices are also published on the CPNI website.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
This update contains important information for community pharmacy teams, including details of the ongoing response to the COVID-19 pandemic.
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter.
Concessionary prices are also published on the CPNI website.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Contractor,
SPPG issued correspondence in relation to Community Pharmacy Medicines Adherence Services. CPNI also issued a Contractor Update related to this which can be found HERE.
ACTION REQUIRED
Return the declaration formby Friday 17 February 2023 to your local SPPG office to provide assurance on the service and funding covering from April 2022 to January 2023.
Return the contractby Friday 17 February 2023 to your local SPPG office to indicate service provision for February and March 2023.
Please do not hesitate to contact the CPNI office if you require any further information.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
